1 Result(s)

Article

NASH limits anti-tumour surveillance in immunotherapy-treated HCC

Hepatocellular carcinoma (HCC) can have viral or non-viral causes^1–5. Non-alcoholic steatohepatitis (NASH) is an important driver of HCC. Immunotherapy has been approved for treating HCC, but biomarker-based stra...

Dominik Pfister, Nicolás Gonzalo Núñez, Roser Pinyol, Olivier Govaere… in Nature (2021)